Unknown

Dataset Information

0

CD47 as a promising therapeutic target in oncology.

ABSTRACT: CD47 is ubiquitously expressed on the surface of cells and plays a critical role in self-recognition. By interacting with SIRPα, TSP-1 and integrins, CD47 modulates cellular phagocytosis by macrophages, determines life span of individual erythrocytes, regulates activation of immune cells, and manipulates synaptic pruning during neuronal development. As such, CD47 has recently be regarded as one of novel innate checkpoint receptor targets for cancer immunotherapy. In this review, we will discuss increasing awareness about the diverse functions of CD47 and its role in immune system homeostasis. Then, we will discuss its potential therapeutic roles against cancer and outlines, the possible future research directions of CD47- based therapeutics against cancer.

SUBMITTER: Zhao H 

PROVIDER: S-EPMC9446754 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

CD47 as a promising therapeutic target in oncology.

Zhao Hai H   Song Shuangshuang S   Ma Junwei J   Yan Zhiyong Z   Xie Hongwei H   Feng Ying Y   Che Shusheng S  

Frontiers in immunology 20220822

CD47 is ubiquitously expressed on the surface of cells and plays a critical role in self-recognition. By interacting with SIRPα, TSP-1 and integrins, CD47 modulates cellular phagocytosis by macrophages, determines life span of individual erythrocytes, regulates activation of immune cells, and manipulates synaptic pruning during neuronal development. As such, CD47 has recently be regarded as one of novel innate checkpoint receptor targets for cancer immunotherapy. In this review, we will discuss  ...[more]

Similar Datasets

Unknown KDM4B: A promising oncology therapeutic target.
| S-EPMC10823266 | biostudies-literature
Unknown P-TEFb as A Promising Therapeutic Target.
| S-EPMC7070488 | biostudies-literature
Unknown Update on FXR Biology: Promising Therapeutic Target?
| S-EPMC6073382 | biostudies-literature
Unknown miRNA: A Promising Therapeutic Target in Cancer.
| S-EPMC9569513 | biostudies-literature
Unknown XIAP represents a promising therapeutic target for relapsed/refractory ALL
| S-SCDT-10_15252-EMMM_202114557 | biostudies-other
Unknown EZH2 in Bladder Cancer, a Promising Therapeutic Target.
| S-EPMC4661858 | biostudies-literature
Unknown Pyroptosis: A promising therapeutic target for noninfectious diseases.
| S-EPMC8560609 | biostudies-literature
Unknown Aurora B: A new promising therapeutic target in cancer.
| S-EPMC5982624 | biostudies-literature
Unknown HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia.
| S-EPMC7498549 | biostudies-literature
Unknown c-Met: A Promising Therapeutic Target in Bladder Cancer.
| S-EPMC9374328 | biostudies-literature